Finance

Beta
Ask
Lists
USPH:NYSE
US Physical Therapy Inc
USD 63,46
+0,99%
(+0,62) 1D
18 Jun., 13:33:56 GMT-4  ·   USD
All symbols
SymbolPriceChange% Change
Generating top insights for USPH...
Open
USD 63,50
High
USD 63,71
Low
USD 62,52
Mkt. cap
963,54 m
Avg. vol.
249,70 k
Volume
66,34 k
Dividend
2,90%
Quarterly dividend
USD 0,46
Ex-dividend date
22 Mei 2026
P/E ratio
126,10
52-wk high
USD 93,50
52-wk low
USD 58,19
EPS
USD 0,50
Beta
1,16
Shares outstanding
15,22 m
No. of employees
6 k
Open
USD 63,50
High
USD 63,71
Low
USD 62,52
Mkt. cap
963,54 m
Avg. vol.
249,70 k
Volume
66,34 k
Dividend
2,90%
Quarterly dividend
USD 0,46
Ex-dividend date
22 Mei 2026
P/E ratio
126,10
52-wk high
USD 93,50
52-wk low
USD 58,19
EPS
USD 0,50
Beta
1,16
Shares outstanding
15,22 m
No. of employees
6 k
Analyst outlook
Analyst Ratings
Based on 5 analysts giving stock ratings to USPH in the past 3 months
Strong Buy
Buy
4
Hold
1
Sell
0
12 month forecast
Based on 5 Wall Street analysts offering 12 month price targets for USPH in the last 3 months.
Highest
Current USD 63,46
USD 98,00 (+54,43%)
Average
USD 92,67 (+46,03%)
Lowest
USD 90,00 (+41,82%)
News stories
From sources across the web
About US Physical Therapy Inc
CEO-
Employees6,37 k
Founded1990
HeadquartersHouston, Texas, Verenigde State van Amerika
SectorHealth care provider
Websiteusph.com
Last report
07 Mei 2026
Fiscal period
Q1 2026
EPS / Est. (USD)
USD 0,46 / USD 0,52
-10,98%miss
Revenue / Est. (USD)
196,28 m / 200,94 m
-2,32%miss
Fiscal Q1 2026 earnings call
Waiting for the earnings call
At a glance
Insights from the latest news and reports
Previous reportsAll values in USD
Loading Previous Earnings...
Income statement
Revenue
Net income
All values in USD
Jun. 2025
Sep. 2025
Des. 2025
Mrt. 2026
Revenue
195,35 m
195,06 m
201,00 m
196,28 m
Cost of goods sold
147,92 m
152,73 m
156,58 m
157,94 m
Cost of revenue
147,92 m
152,73 m
156,58 m
157,94 m
Research and development expenses
-
-
-
-
Total research and development expenses
-
-
-
-
Selling, general, and admin expenses
17,48 m
17,41 m
18,12 m
18,27 m
Operating expense
23,22 m
22,91 m
22,41 m
23,93 m
Total operating expenses
171,13 m
175,64 m
178,99 m
181,87 m
Operating income
24,22 m
19,42 m
22,01 m
14,41 m
Other non operating income
-292,00 k
-441,00 k
198,00 k
494,00 k
EBT including unusual items
22,65 m
22,88 m
14,96 m
10,56 m
EBT excluding unusual items
21,93 m
16,96 m
20,20 m
12,49 m
Income tax expense
4,93 m
5,23 m
5,78 m
2,41 m
Effective tax rate
21,78%
22,88%
38,66%
22,79%
Other operating expenses
-
-
-
-
Net income
12,39 m
13,14 m
4,15 m
5,04 m
Net profit margin
6,34%
6,74%
2,07%
2,57%
Earnings per share
0,81
0,66
0,67
0,46
Interest and investment income
28,00 k
33,00 k
20,00 k
16,00 k
Interest expense
-2,42 m
-2,41 m
-2,35 m
-2,79 m
Net interest expenses
-2,39 m
-2,38 m
-2,33 m
-2,78 m
Depreciation and amortization charges
5,74 m
5,50 m
4,28 m
5,66 m
EBITDA
30,27 m
25,25 m
26,64 m
20,41 m
Gain or loss from assets sale
438,00 k
-18,00 k
-37,00 k
99,00 k
Insider transactions
Insider transactions data is drawn from third-party sources. Learn more
Insider
Position
Type
Date
Shares
Amount
Page 1
AI content may include mistakes. Learn more
AI content may include mistakes. Learn more